| PERIOD ENDING | 27-Mar-09 | 31-Dec-08 | 26-Sep-08 | 27-Jun-08 | | Total Revenue | 3,636,000 | 4,011,000 | 3,662,000 | 3,722,000 | | Cost of Revenue | 3,260,000 | 3,595,000 | 3,262,000 | 3,347,000 | | | Gross Profit | 376,000 | 416,000 | 400,000 | 375,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
|
-
|
-
|
-
| | Non Recurring |
-
|
-
|
-
| (126,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 376,000 | 416,000 | 400,000 | 501,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 6,000 | 7,000 | 7,000 | | Earnings Before Interest And Taxes | 379,000 | 419,000 | 405,000 | 505,000 | | Interest Expense | 66,000 | 71,000 | 68,000 | 61,000 | | Income Before Tax | 313,000 | 348,000 | 337,000 | 444,000 | | Income Tax Expense | 112,000 | 101,000 | 125,000 | 166,000 | | Minority Interest |
-
| (3,000) | (2,000) | (3,000) | | | | Net Income From Continuing Ops | 201,000 | 247,000 | 212,000 | 278,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
| 20,000 |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 201,000 | 267,000 | 212,000 | 278,000 | | Preferred Stock And Other Adjustments | (4,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $197,000 | $267,000 | $212,000 | $278,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
